SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-218405
Filing Date
2024-09-13
Accepted
2024-09-13 06:07:07
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B5 d835505d424b5.htm 424B5 488462
2 EX-FILING FEES d835505dexfilingfees.htm   iXBRL EX-FILING FEES 39090
3 GRAPHIC g835505g00a04.jpg GRAPHIC 55640
  Complete submission text file 0001193125-24-218405.txt   743750

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d835505dexfilingfees_htm.xml XML 8173
Mailing Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453
Business Address 221 CRESCENT STREET SUITE 103A WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-267351 | Film No.: 241296391
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)